- freely available
Inhibition of GTRAP3-18 May Increase Neuroprotective Glutathione (GSH) Synthesis
AbstractGlutathione (GSH) is a tripeptide consisting of glutamate, cysteine, and glycine; it has a variety of functions in the central nervous system. Brain GSH depletion is considered a preclinical sign in age-related neurodegenerative diseases, and it promotes the subsequent processes toward neurotoxicity. A neuroprotective mechanism accomplished by increasing GSH synthesis could be a promising approach in the treatment of neurodegenerative diseases. In neurons, cysteine is the rate-limiting substrate for GSH synthesis. Excitatory amino acid carrier 1 (EAAC1) is a neuronal cysteine/glutamate transporter in the brain. EAAC1 translocation to the plasma membrane promotes cysteine uptake, leading to GSH synthesis, while being negatively regulated by glutamate transport associated protein 3-18 (GTRAP3-18). Our recent studies have suggested GTRAP3-18 as an inhibitory factor for neuronal GSH synthesis. Inhibiting GTRAP3-18 function is an endogenous mechanism to increase neuron-specific GSH synthesis in the brain. This review gives an overview of EAAC1-mediated GSH synthesis, and its regulatory mechanisms by GTRAP3-18 in the brain, and a potential approach against neurodegeneration.
Share & Cite This Article
Aoyama, K.; Nakaki, T. Inhibition of GTRAP3-18 May Increase Neuroprotective Glutathione (GSH) Synthesis. Int. J. Mol. Sci. 2012, 13, 12017-12035.View more citation formats
Aoyama K, Nakaki T. Inhibition of GTRAP3-18 May Increase Neuroprotective Glutathione (GSH) Synthesis. International Journal of Molecular Sciences. 2012; 13(9):12017-12035.Chicago/Turabian Style
Aoyama, Koji; Nakaki, Toshio. 2012. "Inhibition of GTRAP3-18 May Increase Neuroprotective Glutathione (GSH) Synthesis." Int. J. Mol. Sci. 13, no. 9: 12017-12035.
Notes: Multiple requests from the same IP address are counted as one view.